全文获取类型
收费全文 | 1827篇 |
免费 | 135篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 63篇 |
妇产科学 | 46篇 |
基础医学 | 192篇 |
口腔科学 | 25篇 |
临床医学 | 169篇 |
内科学 | 422篇 |
皮肤病学 | 21篇 |
神经病学 | 147篇 |
特种医学 | 273篇 |
外科学 | 167篇 |
综合类 | 38篇 |
一般理论 | 2篇 |
预防医学 | 156篇 |
眼科学 | 27篇 |
药学 | 156篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 48篇 |
出版年
2021年 | 13篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 18篇 |
2017年 | 22篇 |
2016年 | 16篇 |
2015年 | 33篇 |
2014年 | 29篇 |
2013年 | 40篇 |
2012年 | 51篇 |
2011年 | 78篇 |
2010年 | 62篇 |
2009年 | 58篇 |
2008年 | 55篇 |
2007年 | 62篇 |
2006年 | 80篇 |
2005年 | 67篇 |
2004年 | 73篇 |
2003年 | 63篇 |
2002年 | 60篇 |
2001年 | 51篇 |
2000年 | 65篇 |
1999年 | 54篇 |
1998年 | 59篇 |
1997年 | 47篇 |
1996年 | 56篇 |
1995年 | 59篇 |
1994年 | 48篇 |
1993年 | 50篇 |
1992年 | 23篇 |
1991年 | 26篇 |
1990年 | 29篇 |
1989年 | 50篇 |
1988年 | 38篇 |
1987年 | 48篇 |
1986年 | 58篇 |
1985年 | 31篇 |
1984年 | 25篇 |
1983年 | 19篇 |
1982年 | 18篇 |
1981年 | 24篇 |
1980年 | 26篇 |
1979年 | 18篇 |
1978年 | 18篇 |
1977年 | 17篇 |
1976年 | 20篇 |
1975年 | 15篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1957年 | 6篇 |
排序方式: 共有1966条查询结果,搜索用时 0 毫秒
1.
Betsy D. Kennard Susan G. Silva Simon Tonev Paul Rohde Jennifer L. Hughes Benedetto Vitiello Christopher J. Kratochvil John F. Curry Graham J. Emslie Mark Reinecke John March 《Journal of the American Academy of Child and Adolescent Psychiatry》2009,48(2):186-195
ObjectiveWe examine remission rate probabilities, recovery rates, and residual symptoms across 36 weeks in the Treatment for Adolescents with Depression Study (TADS).MethodThe TADS, a multisite clinical trial, randomized 439 adolescents with major depressive disorder to 12 weeks of treatment with fluoxetine, cognitive–behavioral therapy, their combination, or pill placebo. The pill placebo group, treated openly after week 12, was not included in the subsequent analyses. Treatment differences in remission rates and probabilities of remission over time are compared. Recovery rates in remitters at weeks 12 (acute phase remitters) and 18 (continuation phase remitters) are summarized. We also examined whether residual symptoms at the end of 12 weeks of acute treatment predicted later remission.ResultsAt week 36, the estimated remission rates for intention-to-treat cases were as follows: combination, 60%; fluoxetine, 55%; cognitive–behavioral therapy, 64%; and overall, 60%. Paired comparisons reveal that, at week 24, all active treatments converge on remission outcomes. The recovery rate at week 36 was 65% for acute phase remitters and 71% for continuation phase remitters, with no significant between-treatment differences in recovery rates. Residual symptoms at the end of acute treatment predicted failure to achieve remission at weeks 18 and 36.ConclusionsMost depressed adolescents in all three treatment modalities achieved remission at the end of 9 months of treatment. 相似文献
2.
3.
The use of Mixture Toxicity Indices (MTI's) is one of the more attractive approaches for describing and predicting the effects of mixtures of toxicants. For an MTI to apply to all possible mixtures of the compounds in question, it must summarize information from a model describing all possible responses of interest. A method of obtaining MTI's from response surface equations or from tolerance models similar to the toxic units model is presented. Methods of calculating several MTI's with desirable properties from multivariable probit response surfaces are demonstrated. 相似文献
4.
5.
RAFAEL BEYAR M.D. D.Sc. ARIEL ROGUIN M.D. JAAP HAMBURGER M.D. RE SAAIMAN M.D. ANTONIO L. BARTORELLI M.D. CARLO DiMARIO M.D. ANTONIO COLOMBO M.D. CHRISTIAN W. HAMM M.D. CHRISTOPHER J. WHITE M.D. J. MARCO M.D. PATRICK W. SERRUYS M.D. Ph.D. 《Journal of interventional cardiology》1997,10(4):277-286
The beStent is a new stainless steel, balloon-expandable mesh stent which has a unique serpentine design. Rotation of the unique low stress junctions upon expansion leads to orthogonal locking of the wires, maximizing radial strength and assuring zero shortening. The stent has delineating gold markers which assure precise positioning. We aim to present the initial acute results in a pilot registry for stent evaluation. Two hundred eighty-four stents were used in a total of 217 patients (age 57.9 ± 3.10 years; 178 males; 39 females) in seven centers, for variable indications. Stents of 15-, 25-, and 35-mm length were used. The arteries treated were the left anterior descending (n = 112, 42%), circumflex (n = 54, 20.2%), right coronary (n = 95, 35.5%), left main (n = 1, 0.4%), and vein graft (n = 5, 1.9%). Lesion types were: A in 42 patients (16.5%); B1 in 53 patients (20.7%); B2 in 81 patients (31.8%); and C in 79 patients (31%). One hundred fifty-nine patients required one stent, 40 patients required two stents, and 18 patients required three or more stents. Anticoagulation protocol included procedural heparin with aspirin with/without ticlopidine. Smooth angiographie results were obtained in all cases with no plaque herniation. Acute angiographic success was obtained in 97% of the patients, and acute clinical success in 95% of the patients. Complications within 30 days were: 3 deaths (1.4%) (2 noncardiac); 2 (0.9%) myocardial infarctions; and 2 (0.9%) stent thromboses. Therefore, the beStent is useful in treatment of complex lesions of variable length and complexity, providing excellent acute results with a low complication rate, in spite of unfavorable basic clinical and angiographie characteristics. 相似文献
6.
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. 总被引:6,自引:3,他引:3 下载免费PDF全文
1. Male, Long Evans rats were chronically instrumented with pulsed Doppler flow probes and intravascular catheters to permit assessment of the regional haemodynamic responses to human and rat adrenomedullin, to compare the responses to human adrenomedullin to those of human alpha-CGRP in the absence and presence of the CGRP1-receptor antagonist, human alpha-CGRP [8-37], and to determine the involvement of nitric oxide (NO)-mediated mechanisms in the responses to human adrenomedullin, relative to human alpha-CGRP. 2. Human and rat adrenomedullin (0.3, 1, and 3 nmol kg-1, i.v.) caused dose-dependent hypotension and tachycardia, accompanied by increases in renal, mesenteric and hindquarters flows and vascular conductances. At the lowest dose only, the hypotensive and mesenteric vasodilator effects of rat adrenomedullin were significantly greater than those of human adrenomedullin. 3. Human alpha-CGRP at a dose of 1 nmol kg-1 caused hypotension, tachycardia and increases in hindquarters flow and vascular conductance, but reduction in renal and mesenteric flows, and only transient vasodilatations in these vascular beds. These effects were substantially inhibited by human alpha-CGRP [8-37] (100 nmol kg-1 min-1), but those of human adrenomedullin (1 nmol kg-1) were not; indeed, the mesenteric haemodynamic effects of the latter peptide were enhanced by the CGRP1-receptor antagonist. 4. In the presence of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 183 nmol kg-1 min-1), there was only a slight, but significant, inhibition of the hindquarters hyperaemic vasodilator effect of human adrenomedullin, but not that of human alpha-CGRP.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
7.
8.
9.
10.
John S March Martin E Franklin Henrietta Leonard Abbe Garcia Phoebe Moore Jennifer Freeman Edna Foa 《Neuropsychopharmacology》2007,61(3):344-347
BACKGROUND: The presence of a comorbid tic disorder may predict a poorer outcome in the acute treatment of pediatric obsessive-compulsive disorder (OCD). METHODS: Using data from the National Institute of Mental Health (NIMH)-funded Pediatric OCD Treatment Study (POTS) that compared cognitive-behavior therapy (CBT), medical management with sertraline (SER), and the combination of CBT and SER (COMB), to pill placebo (PBO) in children and adolescents with OCD, we asked whether the presence of a comorbid tic disorder influenced symptom reduction on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) after 12 weeks of treatment. RESULTS: Fifteen percent (17 of 112) of patients exhibited a comorbid tic disorder. In patients without tics, results replicated previously published intent-to-treat outcomes: COMB > CBT > SER > PBO. In patients with a comorbid tic disorder, SER did not differ from PBO, while COMB remained superior to CBT and CBT remained superior to PBO. CONCLUSIONS: In contrast to CBT outcomes, which are not differentially impacted, tic disorders appear to adversely impact the outcome of medication management of pediatric OCD. Children and adolescents with obsessive-compulsive disorder and a comorbid tic disorder should begin treatment with cognitive-behavior therapy alone or the combination of cognitive-behavior therapy plus a serotonin reuptake inhibitor. 相似文献